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Seroprevalence of antibodies against
Kaposi's sarcoma-associated herpesvirus
among HIV-negative people in China
Tiejun Zhang1,2, Zhenqiu Liu1,2, Jun Wang1,2, Veenu Minhas3, Charles Wood3, Gary M. Clifford4, Na He1,2*
and Silvia Franceschi4

Abstract
Background: Little information on the prevalence of Kaposi’s sarcoma associated herpesvirus (KSHV) among HIVnegative individuals is available from Asia.
Methods: In the present study, we report findings from a new survey of KSHV in 983 HIV-negative male migrants
from Shanghai and their combination with previous similar surveys of 600 female migrants, 600 female sex-workers
(FSW), 1336 sexually transmitted infection (STI) clinic male patients, 439 intravenous drug-users (IVDU), and 226 men
having sex with men (MSM) from China. KSHV-specific antibodies against latent and lytic antigens were assessed
using Sf9 and BC3 monoclonal immunofluorescence assay. Age-adjusted prevalence ratios (PR) and 95% confidence
interval (95% CI) for KSHV-positivity were estimated using Poisson regression.
Results: In total, 4184 HIV-negative participants were included. KSHV prevalence ranged from 9.8% (95% CI: 7.9%-11.7%)
in male migrants to 32.3% (95% CI: 24.1%-34.1%) in MSM. IVDU show intermediate level (17.5%, 95%CI: 14.1%-21.4%).
KSHV was associated with syphilis (PR = 2.03, 95% CI: 1.38-2.98) in MSM but not in other groups. An association with
human herpes virus 2 was also found among MSM (PR = 1. 83, 95%: 1.22-2.75) but not in migrant workers or FSW.
Conclusions: KSHV prevalence in HIV-negative heterosexuals, FSW, and STI male patients from China is approximately
10%, but 2- and 3-fold higher in IVDU and MSM, respectively. Associations of KSHV with STIs among MSM only suggest
that sexual transmission of the virus is important in MSM but not in heterosexuals.
Keywords: Kaposi’s sarcoma associated herpesvirus, Prevalence, China

Background
Kaposi’s sarcoma-associated herpesvirus (KSHV), also
referred to as human herpesvirus-8 (HHV-8), is the
etiologic agent of KS, primary effusion lymphomas and
multicentric Castleman’s disease (IARC 2012 Vol 100B).
Contrary to other herpesviruses, prevalence of KSHV
varies enormously among regions and sub-populations.
It is generally low (<10%) in the general population in
Northern Europe, the United States and Asia, [1], moderate in the Mediterranean region (10-30%), and high in
sub-Saharan Africa (>30%) (IARC 2012 Vol 100B).
* Correspondence: nhe@shmu.edu.cn
1
Department of Epidemiology, School of Public Health, Fudan University,
Shanghai, China
2
Key Laboratory of Public Health Safety (Fudan University), Ministry of
Education, Shanghai, China
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By far the strongest risk factor for KS is immunosuppression (IARC 2012 Vol 100B). KS risk steeply increases with
the decline in CD4+ count and diminishes rapidly after the
starting of combined antiretroviral therapy (cART) [2]. A
meta-analysis showed that HIV infection was also associated with a two-fold increase in KSHV prevalence, and a
four-fold increase among HIV-positive men having sex
with men (MSM) [3]. In respect to regional variations,
KSHV prevalence in HIV-infected people increases by
two-times or more in Western countries and by 56% in
sub-Saharan Africa but data on the association of the two
infections from Asia are scant [3, 4].
Like other herpesviruses KSHV is primarily transmitted
via saliva and acquisition in KS-endemic areas typically occurs in childhood from the mother or horizontally. Bloodborne transmission exists among injection drug users
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(IVDU) and blood recipients but it is rare. [5, 6] Sexual
transmission is considered important in MSM but has not
been demonstrated in heterosexual individuals. [7–11].
To throw more light on the prevalence and the modalities of KSHV transmission among HIV-negative individuals in China, we carried out a new survey of KSHV
prevalence in male migrant workers. We also combined
the new survey with the findings from five additional
HIV-negative Chinese subpopulations that we had previously studied using the same study protocol [12–15].

Methods
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Syphilis testing

A rapid plasma reagent test (Span Diagnostics Ltd., Surat,
India), was used and confirmed by the Treponema pallidum hemagglutination test (TPHA, Syphagen TPHA,
Biokit, Spain).
HSV-2 testing

HSV-2 IgG antibodies were tested using an ELISA assay
(HerpeSelect 2 ELISA IgG Kit, Focus Technologies, CA,
USA). Equivocal samples were retested using another
ELISA kit (HerpeSelect 2 ELISA IgG Kit, Euroimmun,
Lübeck, Germany).

Male migrant workers

From May to October 2015 we conducted a survey
on the characteristics and prevalence of various infections among male migrant workers in Shanghai,
China (hereinafter referred to as male migrants). The
included migrants were men aged 18 years or older,
had lived in the community for more than 3 months
and were able to provide a written informed consent.
One thousand male migrants were invited and 983 of
them fully complied with study requirements (median
age = 27 years; range: 18-66). They were interviewed
in private by trained staff in Mandarin language using
an anonymized questionnaire that included information on socio-demographic characteristics and sexual
behaviours. Venous blood was collected using sterilized needles and tubes, and transferred to laboratory
within 2 h after collection while maintaining a cold
chain. Plasma samples were stored at −80 °C until
serological testing.
Serology testing
KSHV testing

Plasma samples were tested by two monoclonal immunofluorescence assays (mIFAs) that target KSHV latent and
lytic antigens [16]. Briefly, two serology tests were performed: first, BC-3 cells (KSHV positive and Epstein-Barr
virus negative B cell line, American Type Culture Collection, Manassas, VA), stimulated by tetradecanoyl phorbol
acetate (TPA), were fixed and permeabilized and used for
an enhanced mIFA. Second, Spodoptera frugiperda clone
9 expressing 3 KSHV proteins, ORF73, ORF65 and ORFK8.1, was used. Sera taken from two KS patients and a
normal person were as positive and negative controls,
respectively, in each assay. The two assays were then
compared, and only samples which were positive for both
BC-3 and Sf9 assay at a standard serum dilution of 1:40
were considered KSHV-seropositive. The testing protocol used in our present study have been validated and
shown to have sensitivity of 93.9% and specificity of
96.3% [16]. To guarantee the quality, all slides were
monitored for every batch and were read independently
by two experienced laboratory workers.

HCV testing

Anti-HCV immunoglobulin G (IgG) antibodies were
tested by third-generation ELISA (Wantai Biomedical,
Beijing, China).
HIV testing

HIV antibodies were assessed using ELISA (Vironostika HIV Uni-Form II plus O ELISA Kit, Biomerieux,
Netherland) and confirmed by a western blot assay
(Genelabs Diagnostic, Singapore).
Pooled analysis

The data from the male migrants study were pooled
with those from five additional subpopulations that we
had studied between 2010 and 2015 using similar questionnaires and the same serological assays described
above. Briefly, we included 600 female migrant workers
(age:29.34 ± 8.44), referred to as female migrants [15];
600 female sex workers (FSW) (age: 26.47 ± 6.84) [15];
1336 men attending sexually transmitted infection
clinics, referred to as STI men (age: 37.39 ± 14.13) [12];
439 intravenous drug users (IVDU) (age:45.39 ± 88.41)
[14]; and 226 men having sex with men (MSM) (age:
27.79 ± 7.01) [13]. Thus, a total of 3201 HIV negative
individuals in addition to the aforementioned 983 HIV
negative male migrants were finally included.
All studies had been approved by the Institutional
Review Board (IRB) of Fudan University, Shanghai.
Informed consent was obtained from all subjects, all
study protocols and procedures were in accordance with
the Declaration of Helsinki.
Statistical analysis

The prevalence of KSHV, syphilis, and when available,
HSV2, was examined separately in the six available subpopulations and eventually combined into three groups:
1) heterosexuals, i.e., migrants of both sexes, FSW, and
STI men; 2) IVDU; and 3) MSM (including 27 MSM
who were formerly included in the STI survey [12]). On
account of the limitations and inconsistencies of sexual
history in study questionnaires, the prevalence of syphilis
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and HSV2 was preferred to number of sexual partners as
proxies of sexual activity. Ninety-five percent confidence
intervals (95% CI) of prevalence were computed according
to the normal approximation to the binomial distribution.
Prevalence ratios (PR) and 95% CI for KSHV positivity
were estimated by the Poisson regression models with
robust variance. PRs were adjusted by age group or by age
group and subpopulation as indicated. Risk trends were
assessed by considering categories as continuous variables.
All statistical analyses were carried out using the SAS
System for Windows (Cary, NC, USA), version 8.0.

Results
Among male migrants, only older age (PR for ≥35
vs. <25 = 0.58, 95% CI: 0.34-1.01) and higher education (PR versus primary education = 0.43, 95% CI: 0.230.82, for middle school; and 0.29, 95% CI 0.11-0.80, for
college attendance) were associated with KSHV-positivity
(Table 1). Only 35% of male migrants were living with a
spouse or female partner. The prevalence of antibodies
among male migrants was 9.8% for KSHV (95% CI: 7.9%11.7%), 8.3% for HSV2 (95% CI: 6.7%-10.2%), 0.6% for
syphilis (95% CI: 0.2%-1.3%) (Fig. 1) and 0.4% for HCV
(95% CI: 0.1%-0.9%) (data not shown).
Figure 1 shows variations in the prevalence of KSHV,
syphilis and HSV2 in male migrants and in the other five
sub-populations. KSHV prevalence in male and female
migrants, FSW, and STI men was approximately 10%
and significantly lower than in MSM (32.3%; 95% CI:
24.1%-34.1%). IVDU showed an intermediate KSHV
prevalence (17.5%; 95% CI: 14.1%-21.4%). The prevalence of syphilis ranged from 0.6% (95% CI: 0.2%-1.3%)
in male migrants to 19.9% (95% CI: 14.9%-25.7%) in
MSM and was also significantly elevated (>10%) in FSW
and STI men (Fig. 1b). HSV2 prevalence was significantly higher among FSW (52.1%; 95% CI: 48.1%-56.2%)
and MSM (19.1%; 95% CI: 13.9%-25.3%) as compared
with male (8.3%) and female migrants (15.3%) but it was
not available for STI men and IVDU.
The relationship between KSHV prevalence and syphilis and HSV2 infection in each subpopulation and
pooled PRs according to sexual orientation (heterosexual
or MSM) or IVDU status is shown in Table 2. Syphilis
was significantly associated with KSHV-positivity among
MSM (PR = 2.03, 95% CI: 1.38-2.98) but not in any
group of heterosexual men or women. The pooled PR in
heterosexual subpopulations was 0.97; (95% CI: 0.671.38). Similar results were found for HSV2, i.e., PR = 1.83
(95%:1.22-2.75) in MSM but 1.22 (95% CI: 0.89-1.67) in
the combination of migrant workers and FSW.
Discussion
Our study of HIV-negative men and women from China
shows that KSHV prevalence is approximately 10% in
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Table 1 Sociodemographic characteristics and KSHV infection
among 983 male migrants, Shanghai, 2015
No. (%)

KSHV+ (%)

PR (95%CI)a

18-24

354 (36.0)

39 (11.0)

1.00

25-34

363 (36.9)

40 (11.0)

1.00 (0.66-1.52)

≥ 35

266 (27.1)

17 (6.4)

0.58 (0.34-1.01)

Characteristic
Age (years)

x2trend

= 3.328, P = 0.068

School education
Primary or lower

53 (5.4)

9 (17.0)

1.00

Middle school

846 (86.1)

81 (9.6)

0.43 (0.23-0.82)

College

84 (8.5)

6 (7.1)

0.29 (0.11-0.80)

Never married

463 (47.1)

52 (11.2)

1.00

Ever married

520 (52.9)

44 (8.5)

0.83 (0.51-1.38)

x2trend = 3.028, P = 0.081
Marital status

Stay in Shanghai (yrs)
<1

235 (23.9)

23 (9.8)

1.00

1-2

278 (28.3)

32 (11.5)

1.17 (0.71-1.93)

≥3

470 (47.8)

41 (8.7)

1.01 (0.59-1.69)

≤ 2000

43 (4.4)

7 (16.3)

1.00

2001-4000

677 (68.9)

59 (8.7)

0.54 (0.26-1.01)

> 4000

263 (26.8)

30 (11.4)

0.72 (0.33-1.57)

Alone

163 (16.6)

14 (8.6)

1.00

With a spouse or partner

348 (35.4)

36 (10.3)

1.31 (0.73-2.32)

With others

472 (48.0)

46 (9.7)

1.06 (0.58-1.91)

x2trend = 0.386, P = 0.534
Monthly income (yuan RMB)

x2trend

= 0.101, P = 0.750

Living with

a

Adjusted by age group

migrant workers of both sexes, FSW, and STI men but
2- and 3-fold higher in IVDU and MSM, respectively.
We also found a substantial variability in the prevalence
of syphilis (with peaks of >10% in FSW, STI men, and
MSM) and of HSV2 infection which was detected in
more than half of FSW. However, an association of
KSHV with the two STIs was only present among MSM.
Epidemiological data regarding KSHV prevalence and
KS incidence in HIV-negative populations in Asia is
sparse. Compare to the relatively high prevalence of
KSHV, age-standardized incidence rates of KS in the
fourteen highest-quality cancer registries from China
were consistently below 0.3 per 100,000 in both sexes
and no KS cases was recorded in many registries in the
2003-2007 period [17]. Likewise, similarly low KS incidence is found in other cancer registries from Asia, except for a few registries in Turkey, Israel, and Qatar [17].
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Fig. 1 Prevalence of KSHV (a), Syphilis (b) and HSV2 (c) among different HIV-negative subpopulations China, 2010-2015

Under-report of KS in low/medium-income countries is
a possibility but the likeliest explanation of the coexistence of moderate KSHV prevalence with very low incidence of the disease in China is the relative rarity of
HIV infection in the general population. The rapid
expansion of population-based cancer registries in China
[18] will allow us to understand whether any little studied
Chinese region shows a higher KS burden. Indeed, a large

meta-analysis suggested the existence of areas, notably in
the western part of China, in which KSHV prevalence is
20% or more [4].
Unfortunately, the comparisons of KSHV prevalence
from different studies is hampered by the substantial
variations in the sensitivity of KSHV assays [19], a problem that does not exist in our present surveys in which
two mIFAs were jointly used in one centralized high-
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Table 2 Prevalence ratios (PR) and 95% confidence intervals (95% CI) of KSHV by prevalence of syphilis and HSV2 in individual
subpopulations and pooled PR among heterosexuals, China 2010-2015
HSV2a

Syphilis
No.

KSHV+ (%)

PR (95% CI)b

No.

KSHV+ (%)

PR (95% CI)b

Negative

977

95 (9.7)

1.00

901

87 (9.7)

1.00

Positive

6

1 (16.7)

1.52 (0.25-9.41)

82

9 (11.0)

1.13 (0.59-2.16)

Negative

583

65 (11.1)

1.00

508

55 (10.8)

1.00

Positive

17

1 (5.9)

0.54 (0.08-3.65)

92

11 (12.0)

1.12 (0.61-2.06)

Negative

537

56 (10.4)

1.00

287

25 (8.7)

1.00

Positive

63

4 (6.3)

0.63 (0.28-1.75)

313

35 (11.2)

1.31 (0.81-2.12)

Negative

1167

147 (12.6)

1.00

–

–

–

Positive

169

25 (14.8)

1.07 (0.71-1.62)

–

–

–

Negative

3264

363 (11.1)

1.00

1696

167 (9.8)

1.00

Positive

255

29 (11.4)

0.97 (0.67-1.38)

487

55 (11.3)

1.22 (0.89-1.67)

Negative

427

76 (17.8)

1.00

–

–

–

Positive

12

1 (8.3)

0.51 (0.08-3.40)

–

–

–

Male migrants

Female migrants

Female sex workers

Male STI patients

Total heterosexuals

c,d

Intravenous drug users

e

Men who have sex with men
Negative

181

48 (26.5)

1.00

161

46 (28.6)

1.00

Positive

45

25 (55.6)

2.03 (1.38-2.98)

38

20 (52.6)

1.83 (1.22-2.75)

a

HSV2 findings are based on 2183 individuals only as the test was not done in 1336 STI patients
b
Adjusted by age
c
Additionally adjusted by group
d
Total heterosexuals refer to the Male migrants, Female migrants, Female sex workers and Male STI patients, not Intravenous drug users or Men who have sex
with men
e
HSV2 status was unknown in 27 MSM

quality laboratory [16]. This strength allowed us to explore more reliably the possibility of sexual transmission
of KSHV in HIV-negative individuals. Firstly, we found
no significant variations in KSHV prevalence among
subpopulations of heterosexuals with low-risk (migrant
workers of both sexes) or high-risk (FSW and STI men)
sexual behavior. Secondly, we could demonstrate that
two STIs (syphilis and HSV2) were exclusively predicting
the prevalence of KSHV in MSM.
MSM are at strongly increased risk of KSHV in all
studied populations regardless of HIV status [3, 13, 20].
Number of sexual partners, anal and/or oro-genital
intercourse, and history of STIs are recognized risk
factors for the acquisition of the infection in MSM
[7, 9, 21].
KSHV prevalence in our study was also moderately increased but not associated with the prevalence of syphilis in IVDU. Other studies have provided evidence that
KSHV can be transmitted by blood or blood products
[22–24]. The longer the duration of injection drug use

the higher was the risk of KSHV infection independently
from sexual behavior or demographic differences.
We had already reported lack of association of KSHV
prevalence with the number of sexual partners female
migrants and FSW [15] and in STI men [12] but each
individual survey was relatively small and self-reported
number of sexual partners is not necessarily accurate in
China. The current pooled analysis is based on two
objective measures of sexual habits (syphilis and HSV2)
and represents therefore much stronger evidence of the
low sexual transmissibility of KSHV in different heterosexual subpopulations than self-reported sexual habits.

Conclusions
In conclusion, the present study revealed that KSHV in
China is moderately prevalent among HIV negative heterosexual individuals, but highly prevalent among MSM.
These results may provide insights into potential future
public health impact of KSHV in the HIV negative
population. The results from current study highlight
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opportunities and challenges in this field of study. Definitely
further studies are needed, in order to clarify the potential
risk of KSHV transmission in Chinese population.
Abbreviation
CI: Confidence interval; FSW: Female sex-workers; HCV: Hepatitis C virus;
HIV: Human immunodeficiency virus; HSV2: Herpes simplex virus type 2;
IVDU: Intravenous drug-users; KSHV: Kaposi’s sarcoma associated herpesvirus;
MSM: Men having sex with men; PR: Prevalence ratios
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